Key facts
- 5AM VENTURES is a private equity firm based in SAN FRANCISCO, CA with 18 tracked portfolio companies.
- Notable positions include Latigo Bio, Ensoma, Precede Biosciences, Kinaset Therapeutics, Karius.
- 5AM VENTURES reports $49.9M in regulatory assets under management across 12 private funds, per its SEC Form ADV (2026-03).
Registered with the SEC
Form ADV · 2026-03 · CRD 160395- Regulatory AUM
- $49.9M
- Private fund assets
- $947.0M
- Private funds
- 12 · 9 venture, 2 private equity, 1 hedge
- Staff
- 32
- Registered office
- SAN FRANCISCO, CA
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as 5AM VENTURE MANAGEMENT, LLC).
Free account
See the whole book
- ·The book's top 25 — of 18 recorded positions
- ·Watchlist + alerts for 5AM VENTURES's activity
Create free account
No card required
Portfolio, priced
18 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Latigo Bio | — | $530.0M | — | |
| Ensoma | Drug Discovery | $280.0M | — | |
| Precede Biosciences | — | $198.5M | — | |
| Kinaset Therapeutics | Drug Discovery | $186.0M | — | |
| Karius | — | $185.0M | — | |
| NodThera | — | $151.8M | — | |
| ProLynx | — | $129.0M | — | |
| Mendra | — | $128.0M | — | |
| Renasant Bio | — | $78.0M | — | |
| Fellow | — | $75.0M | — | |
| Wildcat Discovery Technologies | — | $73.0M | — | |
| GlycoEra | — | $70.8M | — | |
| Genuiti Therapeutics | — | — | — | |
| RareCyte | — | — | — | |
| TMRW Life Sciences | — | — | — | |
| + 3 more companies · a free account shows the top of the book | ||||
Frequently asked
- What companies does 5AM VENTURES invest in?
- 5AM VENTURES has 18 recorded portfolio companies, including Latigo Bio, Ensoma, Precede Biosciences, Kinaset Therapeutics.
- What is 5AM VENTURES's AUM?
- 5AM VENTURES manages approximately $49.9M in assets.